LianBio Profile Avatar - Palmy Investing

LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treat…

Biotechnology
US, Princeton [HQ]

Lobbying Analysis

LianBio has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of LIAN's Analysis
CIK: 1831283 CUSIP: - ISIN: US53000N1081 LEI: - UEI: -
Secondary Listings
LIAN has no secondary listings inside our databases.